Found 60 matching trials
Bela 8 Week Dosing PHASE4 The purpose of this study is to transition patients who have been stable on...
Show More Learn More & Join Trial
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT PHASE1 Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagl...
Show More Learn More & Join Trial
Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores NA This will be a pilot study to investigate the use of belatacept (BMS) thera...
Show More Location
University of Maryland
Learn More & Join Trial
Tolerance by Engaging Antigen During Cellular Homeostasis PHASE1 Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Show More Location
Duke University Health System
Learn More & Join Trial
Belatacept for Renal Transplant Recipients With Delayed Graft Function EARLY_PHASE1 Currently looking for individuals that have received a kidney transplant, a...
Show More Location
The Ohio State Universtiy Wexner Medical Center
Learn More & Join Trial
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation PHASE2 The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Show More Location
University of Alabama
Learn More & Join Trial
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention PHASE1 This is a single arm, open label, optimal 2-stage Simon design phase Ib-II ...
Show More Location
NYU Langone Health
Learn More & Join Trial
Islet Transplantation Using Abatacept PHASE2 Islet transplantation in type 1 diabetics with hypoglycemic unawareness usi...
Show More Learn More & Join Trial
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression PHASE4 The purpose of the study is to identify kidney transplant patients that can...
Show More Location
UT Southwestern Medical Center
Learn More & Join Trial
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation PHASE1 Allogeneic hematopoietic cell transplantation (HCT) is one of the only cura...
Show More Location
Washington University School of Medicine
Learn More & Join Trial